Literature DB >> 12592410

Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.

Jason W Myers1, Joshua T Jones, Tobias Meyer, James E Ferrell.   

Abstract

RNA interference (RNAi) is a powerful method for specifically silencing gene expression in diverse cell types. RNAi is mediated by approximately 21-nucleotide small interfering RNAs (siRNAs), which are produced from larger double-stranded RNAs (dsRNAs) in vivo through the action of Dicer, an RNase III-family enzyme. Transfecting cells with siRNAs rather than larger dsRNAs avoids the nonspecific gene silencing of the interferon response, underscoring the importance of developing efficient methods for producing reliable siRNAs. Here we show that pools of 20- to 21-base pair (bp) siRNAs can be produced enzymatically in vitro using active recombinant Dicer. Yields of < or = 70% are obtained, and the siRNAs can be easily separated from any residual large dsRNA by a series of spin columns or gel purification. Dicer-generated siRNAs (d-siRNAs) are effective in silencing transiently transfected reporter genes and endogenous genes, making in vitro dicing a useful, practical alternative for the production of siRNAs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592410     DOI: 10.1038/nbt792

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  68 in total

1.  DEQOR: a web-based tool for the design and quality control of siRNAs.

Authors:  Andreas Henschel; Frank Buchholz; Bianca Habermann
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  Role of lipid metabolism in smoothened derepression in hedgehog signaling.

Authors:  Amir Yavari; Raghavendra Nagaraj; Edward Owusu-Ansah; Andrew Folick; Kathy Ngo; Tyler Hillman; Gerald Call; Rajat Rohatgi; Matthew P Scott; Utpal Banerjee
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

Review 3.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

4.  siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

5.  Cost-effective method of siRNA preparation and its application to inhibit hepatitis B virus replication in HepG2 cells.

Authors:  Zhi-Kang Qian; Bao-Qin Xuan; Tai-Shan Min; Jian-Feng Xu; Lin Li; Wei-Da Huang
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 6.  RNA interference: ready to silence cancer?

Authors:  Simone Mocellin; Rodolfo Costa; Donato Nitti
Journal:  J Mol Med (Berl)       Date:  2005-11-09       Impact factor: 4.599

7.  The contributions of dsRNA structure to Dicer specificity and efficiency.

Authors:  Annaleen Vermeulen; Linda Behlen; Angela Reynolds; Alexey Wolfson; William S Marshall; Jon Karpilow; Anastasia Khvorova
Journal:  RNA       Date:  2005-04-05       Impact factor: 4.942

8.  Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation.

Authors:  Atsushi Iwata; John C Christianson; Mirella Bucci; Lisa M Ellerby; Nobuyuki Nukina; Lysia S Forno; Ron R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

Review 9.  Silence of the transcripts: RNA interference in medicine.

Authors:  Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2005-07-19       Impact factor: 4.599

10.  Association of v-ErbA with Smad4 disrupts TGF-beta signaling.

Authors:  Richard A Erickson; Xuedong Liu
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.